Clinical Trials on Rheumatoid Arthritis in Japan

Total 271 results

Taiho Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.

Rheumatoid Arthritis

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Daiichi Sankyo, Inc.

Completed

AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment (DESIRABLE)

Rheumatoid Arthritis

Japan
Pfizer

Completed

Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

Rheumatoid Arthritis

Japan
Pfizer

Active, not recruiting

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

Rheumatoid Arthritis

Japan
Pfizer

Completed

Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Japan Biological Agent Study Integrated Consortium

Completed

Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan (JESMR)

Rheumatoid Arthritis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Shinshu University
Showa Inan General Hospital

Recruiting

Evaluation of the Condition of Rheumatoid Arthritis After Treatment

Rheumatoid Arthritis

Japan
Nichi-Iko Pharmaceutical Co., Ltd.

Completed

Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Saitama Medical University
Keio University

Unknown

Bucillamine Study of Holding Remission After Infliximab Dose-off

Rheumatoid Arthritis

Japan
Shinshu University

Recruiting

Usefulness of Non TNF Usage in RA Patients

Rheumatoid Arthritis

Japan
Shinshu University

Recruiting

Examination of Efficacy and Safety of Baricitinib in RA Patients

Rheumatoid Arthritis

Japan
Sanofi
Regeneron Pharmaceuticals

Completed

Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Nichi-Iko Pharmaceutical Co., Ltd.

Completed

A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Sanofi
Regeneron Pharmaceuticals

Completed

Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings

Rheumatoid Arthritis

Japan
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL

Rheumatoid Arthritis

Japan
Shinshu University

Recruiting

To Examine Whether or Not the Primary Causes of OA or RA Might be Bone Alterations

Osteoarthritis of Multiple Joints | Progression of Rheumatoid Arthritis

Japan
Atsushi Kawakami
AbbVie GK.

Recruiting

Discontinuation of Methotrexate in Rheumatoid Arthritis Patients Achieving Clinical Remission by Treatment With Upadacitinib Plus Methotrexate (DOPPLER)

Rheumatoid Arthritis | Biomarker | JAK Inhibitor | Musculoskeletal Ultrasound

Japan
Keio University
Saitama Medical University

Unknown

Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate

Rheumatoid Arthritis

Japan
Chugai Pharmaceutical

Completed

A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)

Rheumatoid Arthritis

Japan
Abbott
Eisai Co., Ltd.

Completed

Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis

Juvenile Rheumatoid Arthritis

Japan
Atsushi Kawakami
Gilead Sciences

Recruiting

Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate (TRANSFORM)

Rheumatoid Arthritis | Biomarker | JAK Inhibitor | Musculoskeletal Ultrasound | IL-6 Inhibitor

Japan
Eli Lilly and Company

Completed

A Study of LY2439821 in Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Zimmer Biomet

Recruiting

ROSA Knee Intraoperative Planning Flexibility Study (IntraOP)

Rheumatoid Arthritis | Osteo Arthritis Knee

Japan
Astellas Pharma Inc

Completed

Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Japan
Chugai Pharmaceutical

Terminated

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Kobe University

Unknown

Quality of Sleep in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Eli Lilly and Company

Completed

A Study in Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Abbott
Eisai Co., Ltd.; Abbott Japan Co.,Ltd

Completed

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Astellas Pharma Inc
UCB Japan Co. Ltd.

Completed

Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870

Active Rheumatoid Arthritis

Japan
Eli Lilly and Company

Completed

A Study of Japanese Rheumatoid Arthritis Participants

Rheumatoid Arthritis

Japan
Chugai Pharmaceutical

Completed

PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)

Rheumatoid Arthritis

Japan
Eli Lilly and Company

Completed

A Study for Japanese Participants With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Japan
Chiba University

Completed

Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis (OPTIWIT)

Arthritis, Rheumatoid

Japan
Stryker Japan K.K.

Completed

Scorpio Non Restricted Geometry (NRG) Study in Japan

Osteoarthritis | Rheumatoid Arthritis

Japan
Pfizer

Completed

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

Arthritis, Rheumatoid

Japan
Otsuka Pharmaceutical Co., Ltd.
UCB Japan Co. Ltd.

Completed

Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Japan
Ablynx

Completed

Study Evaluating Multiple Ascending Doses Of ATN-103 In Japanese Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Astellas Pharma Inc

Completed

A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate

Rheumatoid Arthritis (RA)

Japan
Astellas Pharma Inc
UCB Japan Co. Ltd.

Completed

Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients

Rheumatoid Arthritis

Japan
Astellas Pharma Inc
UCB Japan Co. Ltd.

Completed

Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients

Rheumatoid Arthritis

Japan
Otsuka Pharmaceutical Co., Ltd.
UCB Japan Co. Ltd.

Completed

Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Japan
Astellas Pharma Inc

Completed

A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate

Rheumatoid Arthritis

Japan
Astellas Pharma Inc
UCB Japan Co. Ltd.

Completed

Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Abbott
Eisai Co., Ltd.; Abbott Japan Co.,Ltd

Completed

Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Astellas Pharma Inc

Completed

A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients

Rheumatoid Arthritis

Japan
LG Life Sciences
Mochida Pharmaceutical Company, Ltd.

Completed

A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Arthritis, Rheumatoid

Japan, Korea, Republic of
LG Life Sciences
Mochida Pharmaceutical Company, Ltd.

Unknown

A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Arthritis, Rheumatoid

Japan, Korea, Republic of

3

Subscribe